• 3 podium presentations (Patient access schemes in UK are driven by Health Technology Assessment; Influence of HTA and hospital funding systems on patient access to innovating medicines: example of advanced renal cell cancer in Western Europe; Huntington quality of life interview (HQOLI): a new Huntington disease specific quality of life instrument)
• 1 workshop (How to address regional market access hurdles in decentralized European countries)
• 1 issue panel (Rare (Orphan) disease: tension between government support of developing new therapies and reimbursement processes? Perspectives from EU-5 (Germany, UK, France, Spain and Italy), Central East Europe, USA and Canada)
• 8 posters (Impact of methodological choices and assumptions in economic evaluations of rotavirus vaccination;
“Two years after set-up, the company has contributed to many works and publications, and the ISPOR Congress is a great occasion for us to showcase our expertise. This year Creativ-Ceutical will have its own booth and we will be pleased to discuss our various posters and presentations as well as future collaboration and partnerships”
Creativ-Ceutical looks forward to meeting you soon at booth #59.
# # #
Creativ-Ceutical performs strategic pricing, market access, health economics and outcomes research for the life sciences. Founded in 2008, the company now has offices in Luxembourg, France, the UK and Tunisia.